PHARMASEAL AND LEDGER RUN FORGE PARTNERSHIP TO ENHANCE CLINICAL BUSINESS OPERATIONS

Leading life science technology companies to simplify clinical research activities and improve operational processes with integrated software solution

NOTTINGHAM, United Kingdom and TIBURON, CA, October 3, 2024: PHARMASEAL specializes in state-of-the-art trial management software for life sciences (unified CTMS/eTMF) and LEDGER RUN, INC., an innovative technology company focused on optimizing clinical operations in the areas of site budgeting, contracts and payments, announced their partnership today. Through the partnership, PHARMASEAL’S Engility® Platform software Engility CTMS, Engility eTMF and LEDGER RUN'S unique ClinRun™ platform will streamline and enhance clinical operation budgeting and payment processes with an intelligent approach and seamless integration.

"PHARMASEAL’s team has 30 years of success developing software solutions that deliver functional and leading edge eClinical software.  We help our customers to continuously optimize the clinical development processes by providing intuitive, affordable and rapidly implementable CTMS and eTMF systems" said Daljit Cheema, CEO at PHARMASEAL. "Partnering with LEDGER RUN will further enhance our ability to tailor our digital solutions to enable our customers to optimize their clinical operations including payments and budgeting. We are excited to work with a company creating complementary, next-generation software to provide a broader set of functions for our customers."

"The industry is facing increasingly complex study designs, new challenges as clinical trials become more complicated. The partnership will create an integrated solution to meet these challenges and provide a more attractive solution to market through a broader set of capabilities for our customers," said Gary Lubin, Chief Executive Officer, LEDGER RUN.  "Our site activation and payment capabilities, along with PHARMASEAL’seClinical trial management platform, will make it easier for our customers to manage their clinical trial business operations and assist in the continuous improvement of these critical processes."

Daljit Cheema and Gary Lubin added, we are excited that the two companies are working together to deliver a broader Clinical Operations platform based on market leading systems. Furthermore, we see this as another step forward in our investment in technologies that support improving patients' lives through enhanced clinical trial services. 

About PHARMASEAL INTERNATIONAL LIMITED

PHARMASEAL International Ltd, established in 2016, was founded with a vision to create a unified trial management platform that supports global life science organizations in managing clinical trials aimed at improving human health. The company's team of clinical technology experts designed and developed the Engility® Trial Management platform to alleviate the burdens of clinical operations, enhance collaboration and oversight, and provide a unified suite that boosts clinical operations productivity.  The Engility platform is engineered on a modern cloud architecture and designed to scale efficiently for all types of trials. Visit www.pharmaseal.co to book a demo 

About LEDGER RUN

LEDGER RUN Inc. is transforming the clinical trial business operations process through an innovative suite of trial management solutions. LEDGER RUN's next-generation software suite, ClinRun™, makes it easy to activate and pay sites. The ClinRun platform of budgeting, contracting, payments, and forecasting automates manual tasks, reduces errors, and speeds cycle times while promoting engagement with investigator sites. ClinRun is simple to implement and can manage the most complex studies.  For more information, please visit us at www.ledgerrun.com or contact Info@ledgerrun.com

Media Contacts

PHARMASEAL INTERNATIONAL LIMITED

Sally Vernon 

Marketing

sally.vernon@pharmaseal.co

LEDGER RUN, Inc.

Zach Hector

VP of Sales, and Business Development  

Zach.Hector@ledgerrun.com